2 completed, 1 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow PharmaDiall Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19 Dimolegin, Clexane - COVID-19, Venous Thromboembolism | Phase 3 | Completed | PharmaDiall Ltd. | 399 | 2021-02-08 | 2022-01-11 |
| A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement Dimolegin 40 mg, Dimolegin 60 mg, Fragmin - Venous Thromboembolism | Phase 2 | Unknown | PharmaDiall Ltd. | 240 | 2019-05-31 | 2022-05-02 |
| A Study of Pharmacokinetics, Safety and Tolerability of Dimolegin (DD217) Dimolegin - Healthy Volunteers | Phase 1 | Completed | PharmaDiall Ltd. | 24 | 2017-01-25 | 2022-01-06 |
Venous Thromboembolism (2) · COVID-19 (1) · Pulmonary Embolism (1) · Thrombosis (1) · Venous Thrombosis (1)
(+-)-(1'R*,2'S*,6'R*)-(2-hydroxy-4,6-dimethoxyphenyl)(3'-methyl-2'-(3''-methylbut-2''-enyl)-6-phenylcyclohex-3'-enyl)methanone (3) · Dalteparin (1) · Enoxaparin (1) · enoxaparin sodium (1)
Russia (3)